Icosavax Provides Corporate Update and Anticipated Milestones for 2023

January 6, 2023

https://www.globenewswire.com/news-release/2023/01/06/2584395/0/en/Icosavax-Provides-Corporate-Update-and-Anticipated-Milestones-for-2023.html

– Recently reported positive six-month immunogenicity data for IVX-121 against RSV; first clinical evidence of potential differentiation on durability with company’s VLP platform –

Read more at globenewswire.com

Related news for (ICVX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.